Zhejiang Jingxin Pharmaceutical Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No.800, Xinchang Ave. East Rd., Yulin St., Xinchang County, Shaoxing, Zhejiang 312500, China (CHN)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 2000033505 · DUNS 654209998
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-10-17
Drugs this plant is listed as making
3 distinct drugs across 13 products name this site in their FDA label.
- Amitriptyline HydrochlorideAiPing Pharmaceutical, Inc.
- Losartan PotassiumAiPing Pharmaceutical, Inc.
- RosuvastatinAiPing Pharmaceutical, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.